Major shareholder announcement – BlackRock, Inc.
18 3월 2024 - 8:32PM
Major shareholder announcement – BlackRock, Inc.
ANNOUNCEMENT NO. 258
Major shareholder announcement
Major shareholder announcement – BlackRock,
Inc.
Pursuant to Section 30 of the Capital Markets Act,
it is hereby announced that BlackRock, Inc. has informed ChemoMetec
A/S that BlackRock Investment Management (UK) Limited on 14 March
2024, increased its holding of shares and voting rights in
ChemoMetec A/S to above 10%, and that the holding thus exceeds the
10 per cent limit in section 38 of the Capital Markets Act.
The aggregate holding of shares and voting rights
of BlackRock, Inc. in ChemoMetec A/S amounts to 12,56% of the total
share capital and voting rights in ChemoMetec A/S.
Additional information
Niels Høy Nielsen, CFOTelephone (+45) 2551 8724
About ChemoMetec A/S
ChemoMetec develops, manufactures and markets
instruments for cell counting and a wide range of other
measurements. ChemoMetec’s instruments are marketed to the
pharmaceutical, biotech and agricultural industries worldwide.
ChemoMetec’s customers include some of the world’s leading
pharmaceutical companies, such as Novartis, Novo Nordisk, H.
Lundbeck, Merck, AstraZeneca and Johnson & Johnson.
ChemoMetec was founded in 1997 and is listed on
Nasdaq OMX Copenhagen. For more information, go to
www.chemometec.com
Chemometec AS (TG:CHY)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Chemometec AS (TG:CHY)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
